Log In
BCIQ
Print this Print this
 

dl5-29 HSV-2 vaccine (HSV-529) (formerly ACAM-529)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionVaccine containing replicative-defective herpes simplex virus type 2 (HSV-2)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat herpes simplex virus type 2 (HSV-2) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/16/2014

Undisclosed

0

Undisclosed

Get a free BioCentury trial today